Health Monitor Acquires D+R Lathian, Forging an Omnichannel Powerhouse in Pharma Marketing

MONTVALE, NJ – May 07, 2026 – Health Monitor Network, a dominant force in point-of-care (POC) marketing, today announced its acquisition of D+R Lathian, a specialized digital marketing firm renowned for its deep engagement with healthcare professionals (HCPs). The move creates a formidable new entity in the healthcare marketing landscape, combining Health Monitor's vast physical network in physician offices with D+R Lathian's sophisticated digital targeting capabilities.

The acquisition, terms of which were not disclosed, is a clear signal of Health Monitor's ambitious growth strategy. It aims to create a single, integrated platform for pharmaceutical, biotech, and medical device companies to reach both patients and their doctors across the entire healthcare journey. By integrating D+R Lathian's proprietary MyDrugRep.com platform and its data-driven expertise, Health Monitor is poised to offer a more comprehensive and measurable solution than ever before.

“This strategic acquisition reflects our commitment to growth and innovation, and to offering our trusted pharma brand partners the broadest omnichannel platform in point of care,” said David Paragamian, Chief Executive Officer of Health Monitor Network, in a statement. “D+R Lathian brings highly complementary strengths in HCP activation and omnichannel execution. Together, we will deliver deeper audience insights and more effective engagement with both healthcare professionals and patients.”

A Strategic Play for Market Dominance

For over 40 years, Health Monitor has built its reputation by placing educational content directly at the point of care—in the waiting rooms and exam rooms of over 250,000 medical offices. This acquisition, however, is a decisive move beyond its traditional stronghold. It directly addresses a fundamental challenge for pharmaceutical brands: how to effectively engage busy healthcare professionals in an increasingly fragmented and access-restricted environment.

D+R Lathian provides the missing piece of the puzzle. With 25 years of experience focused exclusively on HCP engagement, the company developed powerful digital tools to cut through the clutter. Its flagship MyDrugRep.com portal, an invite-only platform, provides medical content to a verified audience of over 806,000 physicians. Its key differentiator lies in its ability to target and track engagement at the individual provider level (NPI-level matching), a critical capability for measuring campaign effectiveness and ROI.

By merging Health Monitor’s extensive physical footprint with D+R Lathian's digital precision, the combined company can now offer a uniquely powerful value proposition. A pharmaceutical brand can now coordinate a campaign that touches a physician through an in-office digital screen, follows up with a targeted email linking to a clinical paper on MyDrugRep.com, and provides print materials for patient discussions—all managed and measured through a single partner. This integrated approach is designed to resonate with an industry grappling with patent expirations, slower pipelines, and the perennial challenge of securing time with physicians.

Reide Rosen, a Co-Founding Partner at D+R Lathian, highlighted the alignment of their goals. “Health Monitor Network and D+R Lathian share a common mission to improve health outcomes through precise, innovative, omnichannel marketing,” he stated. “By joining the Health Monitor organization, we can create more connected brand experiences and deliver stronger results for our clients across the healthcare ecosystem.”

Redefining the 'Point of Care'

This deal fundamentally expands the definition of 'point of care' marketing. Historically confined to the physical clinic, the concept is now evolving into a continuous, multi-channel engagement strategy. The acquisition acknowledges that the moments influencing clinical decisions and patient conversations happen both inside and outside the exam room.

The modern HCP journey is a hybrid of physical and digital interactions. A physician might see a product message on a screen in their office, research it later on a trusted digital portal, receive a follow-up from a virtual sales rep, and finally discuss it with a patient using a branded educational tool. The new Health Monitor entity is structured to own that entire journey.

The synergy allows for a level of message sequencing and personalization that was previously difficult to achieve. For instance, D+R Lathian's data-driven 'Next Best Action' models can now be powered by insights from Health Monitor’s vast network, creating a feedback loop that continually refines outreach. This shift from siloed channels to an integrated ecosystem reflects a broader digital transformation across healthcare, where the goal is to provide seamless, relevant information to the right person at the right time.

The Private Equity Blueprint for Growth

Fueling this strategic expansion is Gridiron Capital, the investment firm that backs Health Monitor Network. The acquisition of D+R Lathian is a textbook execution of a private equity growth strategy, falling squarely within Gridiron's “outsourced pharmaceutical services” area of expertise. This investment thesis posits that specialized service providers are essential for helping the massive pharmaceutical industry navigate its complex challenges.

Rather than being a passive financial partner, Gridiron actively works with its portfolio companies to accelerate growth through both organic development and strategic M&A. The firm's playbook involves identifying a strong platform company—in this case, Health Monitor—and providing the capital and strategic guidance to acquire complementary businesses that enhance its capabilities and consolidate a fragmented market. This approach allows companies to scale rapidly and build a defensible leadership position.

By backing the D+R Lathian purchase, Gridiron is enabling Health Monitor to build an end-to-end platform that is difficult for smaller, less-capitalized competitors to replicate. This move is not just about adding a new service line; it's about constructing a comprehensive solution that becomes indispensable to major pharmaceutical clients, thereby securing larger, longer-term contracts and increasing market share.

Impact on Pharma and the Competitive Landscape

For pharmaceutical and life sciences clients, the merger promises a more streamlined and powerful way to execute marketing strategies. The ability to partner with a single entity for broad-reach patient education and precision-targeted HCP engagement simplifies campaign management and, crucially, provides a unified view of performance analytics. In an industry where proving ROI is paramount, the ability to connect disparate touchpoints into a measurable campaign is a significant advantage.

The combined entity will offer clients access to one of the largest proprietary healthcare networks in the industry, now enhanced with best-in-class digital tactics that boast engagement rates far exceeding industry benchmarks. This integration of high-performing digital and print channels with a massive physical POC network sets a new standard for what it means to be an omnichannel marketing partner.

This move also sends a clear message to the competition. Other agencies, whether large holding company networks or smaller digital-first shops, will now face a competitor with a unique and deeply integrated offering. The new Health Monitor Network challenges the traditional divide between patient-focused POC marketing and professional-focused digital engagement, forcing others in the market to re-evaluate their own service integration and ability to deliver a truly holistic solution. As the healthcare landscape continues its rapid digital evolution, this strategic combination positions Health Monitor to not only adapt but to lead the charge in defining the future of communication between brands, doctors, and patients.